MetaOptics Ltd Announces Intention to Seek Dual Listing on NASDAQ

Key Highlights and Important Details for Shareholders

MetaOptics Ltd (Company Registration No.: 419911, incorporated in the Cayman Islands) has issued a significant announcement regarding its strategic plans to seek a dual listing on the NASDAQ Stock Market in New York, USA. The Board of Directors has outlined several critical points that current and potential investors should take note of, as these developments could potentially impact the company’s future valuation and share price.

1. Intention to Dual List on NASDAQ

• The company is proposing to seek a dual listing on NASDAQ, which, if successful, would allow its securities to be traded on one of the world’s most prominent stock exchanges.
• This move is aimed at providing an additional quoted platform for the trading of MetaOptics’ securities, increasing access to a diverse base of institutional and private investors in the USA.
• The dual listing is expected to enhance the company’s flexibility to raise capital and pursue strategic investment activities such as mergers and acquisitions in North America.
• If successful, this could result in improved trading liquidity for MetaOptics shares, owing to a wider and more diverse shareholder base.

2. Strategic Rationale Behind the NASDAQ Listing

• The Board believes that the NASDAQ listing presents an excellent opportunity for MetaOptics to expand its metalens design and fabrication capabilities within the USA.
• Being present in the USA would position the company closer to key customers and facilitate the advancement of next-generation optical technologies across multiple sectors.
• This move aligns with the company’s objective of leveraging its technological expertise in strategic markets and supporting its growth ambitions.

3. Appointment of Professional Advisers

• MetaOptics has initiated the process of appointing essential professional advisers, including a lead underwriter, legal adviser, and external auditor, to oversee the proposed NASDAQ listing.
• This indicates that preparatory work is ongoing, but as of the announcement date, no formal application has been submitted to NASDAQ, the SEC, or the Singapore Exchange (SGX-ST).

4. Cautionary Statement and Risks

• The Board emphasizes that the proposed NASDAQ listing is still at a preliminary stage and is subject to several conditions, including:
  • Satisfactory completion of due diligence by appointed advisers
  • Approval from regulatory authorities such as NASDAQ and the SEC
  • Shareholder approval and potentially additional approval from the SGX-ST
  • Prevailing market conditions at the time of application
• There is no assurance or certainty that the application will be made or that the NASDAQ listing will materialize.
• Even if all regulatory and shareholder approvals are obtained, the Board may decide not to proceed depending on economic and capital market conditions.
• Shareholders and potential investors are strongly advised to exercise caution when dealing in the company’s shares, as the outcome and timing of the NASDAQ listing remain uncertain.

5. Ongoing Updates

• The company commits to keeping shareholders informed through timely announcements regarding material developments and progress related to the proposed NASDAQ listing.
• Contact details for investor relations and the company’s sponsor (ZICO Capital Pte. Ltd.) are provided for further inquiries.

6. Potential Price-Sensitive Information

• The move to list on NASDAQ is a potentially price-sensitive development, given its implications for shareholder base expansion, capital raising capability, and strategic positioning in the US market.
• Uncertainty concerning the completion and success of the listing could introduce volatility in the company’s share price.
• Shareholders are advised to monitor further announcements closely and consult their professional advisers before making investment decisions.

Contact Information

For more information, shareholders can contact MetaOptics Ltd at [email protected]. The company’s sponsor, ZICO Capital Pte. Ltd., can be reached at 77 Robinson Road, #06-03 Robinson 77, Singapore 068896, telephone: (65) 6636 4201.

Disclaimer

This article is for informational purposes only and does not constitute an offer or solicitation to buy or sell any securities. Investors should exercise caution and consult their legal, financial, tax, or other professional advisers before making any investment decisions. The proposed NASDAQ listing is subject to regulatory, shareholder, and market conditions, and there is no assurance that it will proceed or succeed.

View METAOPTICS LTD Historical chart here